KPTI20270219P15
KPTI Feb 19 2027 15.00 Put (KPTI270219P00015000)
option OPRA

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com